v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 26, 2026
Sep. 27, 2025
Sep. 26, 2026
Sep. 27, 2025
Income Statement [Abstract]        
Net sales $ 7,856 $ 7,115 $ 22,893 $ 20,645
Cost of goods sold 5,931 5,240 16,912 15,041
Gross profit 1,925 1,875 5,981 5,604
Operating expense        
Selling, general and administrative expenses 1,259 1,116 3,782 3,259
Amortization of intangible assets 176 177 529 528
Other operating (income) expenses, net (10) 8 353 30
Total operating expense 1,425 1,301 4,664 3,817
Operating income 500 574 1,317 1,787
Other expense        
Interest expense, net (118) (213) (373) (646)
Other loss, net (1) (6) (42) (6)
Foreign exchange gain (loss), net 5 (10) 10 (93)
Total other expense (114) (229) (405) (745)
Income before income taxes 386 345 912 1,042
Provision for income taxes 68 23 216 65
Net income 318 322 696 977
Net income attributable to noncontrolling interests 123 0 312 0
Net income attributable to Medline Inc. $ 195 322 $ 384 977
Earnings per share attributable to Medline Inc.        
Basic (in dollars per share) $ 0.23   $ 0.46  
Diluted (in dollars per share) $ 0.22   $ 0.45  
Weighted-average number of Class A common stock outstanding        
Basic (in shares) 876,467,488   851,211,179  
Diluted (in shares) 1,316,405,914   1,316,765,474  
Other comprehensive income (loss), net of tax        
Net unrealized loss on derivative instruments $ (10) (20) $ (22) (70)
Currency translation adjustment 13 10 (26) 111
Total other comprehensive income (loss), net of tax 3 (10) (48) 41
Total comprehensive income 321 312 648 1,018
Comprehensive income attributable to noncontrolling interests 124 0 295 0
Comprehensive income attributable to Medline Inc. $ 197 $ 312 $ 353 $ 1,018